封面
市場調查報告書
商品編碼
1594544

核酸檢測市場:按適應症、按產品、按方法、按最終用戶 - 2025-2030 年全球預測

Nucleic Acid Testing Market by Indication (Cancer, Forensic Testing, Genetic & Mitochondrial Disorders), Product (Consumables, Nucleic Acid Test Kits), Technique, End User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

根據預測,2023年核酸檢測市場價值為34.3億美元,預計2024年將達到37.9億美元,複合年成長率為10.30%,到2030年將達到68.3億美元。

核酸檢測 (NAT) 是分子診斷市場的重要組成部分,能夠檢測和擴增 DNA 和 RNA 等遺傳物質,以識別病原體和異常情況。這項需求源於對準確診斷工具不斷成長的需求,特別是考慮到 COVID-19 大流行和感染疾病增加等全球健康挑戰。 NAT 的應用領域包括血液篩檢、感染疾病診斷和腫瘤學,服務於醫療保健環境、研究機構和生物技術公司。關鍵的成長要素包括擴增方法的技術進步、醫療保健支出的增加以及早期疾病檢測意識的提高。此外,由遺傳和基因組資料驅動的個人化醫療正在擴大精準治療的機會。然而,市場面臨著測試成本高、監管障礙以及需要專門的測試基礎設施等挑戰,這可能會阻礙廣泛採用,尤其是在低度開發地區。也就是說,在即時檢測創新和開發侵入性較小的樣本採集方法方面存在令人興奮的機會,以促進方便用戶使用和快速的檢測解決方案。人工智慧和機器學習與 NAT 的整合還有可能徹底改變資料解釋並提高診斷準確性和吞吐量。為了實現業務成長,公司應專注於開發可攜式、經濟高效的套件,以減少對複雜實驗室環境的依賴,這是一個成熟的研究和開發領域。與醫療保健提供者合作以了解他們的具體需求並夥伴關係以擴展到新興市場可以提高競爭力。隨著市場逐漸走向分散式檢查環境,提供可擴展和標準化解決方案的能力將變得至關重要。保持領先地位需要持續回應監​​管環境並靈活適應不斷發展的技術環境,特別是行動醫療應用的新可能性。

主要市場統計
基準年[2023] 34.3億美元
預測年份 [2024] 37.9億美元
預測年份 [2030] 68.3億美元
複合年成長率(%) 10.30%

市場動態:揭示快速發展的核酸檢測市場的關鍵市場洞察

供需的動態交互作用正在改變核酸檢測市場。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 癌症和其他感染疾病患者增加
    • 人類基因檢測的商業化程度提高
    • 流行病防範和消除的需求迅速增加
  • 市場限制因素
    • 龐大的研發成本
  • 市場機會
    • 有吸引力的資金籌措場所和政府支持擴大檢測能力
    • 增加政府核准和報銷
  • 市場挑戰
    • 複雜的設備和技術

波特五力:駕馭核酸檢測市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰,以確保更強大的市場地位。

PESTLE分析:了解外部對核酸檢測市場的影響

外部宏觀環境因素在塑造核酸檢測市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解核酸檢測市場競爭狀況

對核酸檢測市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣核酸檢測市場廠商績效評估

FPNV定位矩陣是評估核酸檢測市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商,以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了核酸檢測市場的成功之路

對於旨在加強在全球市場的影響力的公司來說,對核酸檢測市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

本報告對市場進行了全面分析,涵蓋關鍵重點領域:

1. 市場滲透率:對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓:辨識新興市場的成長機會,評估現有領域的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,幫助相關人員做出明智的決策:

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品、區隔市場和地區提供最佳投資機會?

3.塑造市場的主要技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 癌症和其他感染疾病的增加
      • 人類基因檢測的商業化程度提高
      • 控制和消除疫情的迫切需要
    • 抑制因素
      • 巨額研發投入
    • 機會
      • 有吸引力的資金空間和政府支持擴大檢測能力
      • 增加政府核准和報銷
    • 任務
      • 複雜的儀器和技術
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 核酸檢測市場依適應症分類

  • 癌症
  • 刑事鑑定
  • 遺傳和粒線體疾病
  • 感染疾病

第7章 核酸檢測市場:依產品

  • 消耗品
  • 核酸檢測套組

第8章 核酸檢測市場:依技術分類

  • 探針放大系統
  • 訊號放大
  • 目標放大系統

第9章 核酸檢測市場:依最終用戶分類

  • 醫院
  • 病理實驗室
  • 調查機構

第10章 南北美洲核酸檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區核酸檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲核酸檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 23andMe, Inc.
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • ARUP Laboratories
  • Asuragen Inc.
  • Beckman Coulter, Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomerieux SA
  • Cepheid
  • F. Hoffmann-La Roche Ltd.
  • Gen-Probe, Inc.
  • Illumina, Inc.
  • Novartis AG
  • Thermo Fisher Scientific Inc.
Product Code: MRR-036C5CF3B554

The Nucleic Acid Testing Market was valued at USD 3.43 billion in 2023, expected to reach USD 3.79 billion in 2024, and is projected to grow at a CAGR of 10.30%, to USD 6.83 billion by 2030.

Nucleic Acid Testing (NAT) represents a significant segment within the molecular diagnostics market, equipped to detect and amplify genetic material like DNA and RNA to identify pathogens or anomalies. Its necessity stems from the growing demand for accurate diagnostic tools, especially in light of global health challenges such as the COVID-19 pandemic and rising incidences of infectious diseases. NAT's applications span across diverse segments including blood screening, infectious disease diagnosis, and oncology, serving healthcare settings, research institutions, and biotechnology firms. Key growth factors include technological advancements in amplification methods, increased healthcare expenditures, and heightened awareness of early disease detection. Moreover, personalization in medicine, driven by genetic and genomic data, opens opportunities in precision therapies. However, the market faces challenges such as high test costs, regulatory hurdles, and the requirement for specialized laboratory infrastructure, which could hamper widespread adoption, especially in underdeveloped regions. Nevertheless, exciting opportunities lie in point-of-care testing innovations and the development of less invasive sample collection methods, fostering user-friendly and rapid testing solutions. The integration of AI and machine learning with NAT could also revolutionize data interpretation, enhancing diagnostic accuracy and throughput. For business growth, companies should focus on developing portable, cost-effective nucleic acid testing kits that reduce dependency on complex lab settings, an area ripe for research and development. Collaborations with healthcare providers to understand specific needs and partnerships for expanding into emerging markets can provide a competitive edge. As the market gradually transitions towards decentralized testing environments, the ability to offer scalable and standardized solutions will be crucial. To stay ahead, continuous focus on regulatory compliance and agile adaptation to evolving technological landscapes will be necessary, especially concerning emerging potential for mobile health applications.

KEY MARKET STATISTICS
Base Year [2023] USD 3.43 billion
Estimated Year [2024] USD 3.79 billion
Forecast Year [2030] USD 6.83 billion
CAGR (%) 10.30%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nucleic Acid Testing Market

The Nucleic Acid Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising cases of cancer and other infectious diseases
    • Increased commercialization of human genetic tests
    • Exponential need in pandemic control and eradication
  • Market Restraints
    • Huge expenditure on R&D
  • Market Opportunities
    • Attractive funding space and government support to expand testing capabilities
    • Increasing government approvals and reimbursements available
  • Market Challenges
    • Complex instrumentation and technology

Porter's Five Forces: A Strategic Tool for Navigating the Nucleic Acid Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nucleic Acid Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nucleic Acid Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nucleic Acid Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nucleic Acid Testing Market

A detailed market share analysis in the Nucleic Acid Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nucleic Acid Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nucleic Acid Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nucleic Acid Testing Market

A strategic analysis of the Nucleic Acid Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nucleic Acid Testing Market, highlighting leading vendors and their innovative profiles. These include 23andMe, Inc., Abbott Laboratories, Agilent Technologies, Inc., ARUP Laboratories, Asuragen Inc., Beckman Coulter, Inc., Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Biomerieux SA, Cepheid, F. Hoffmann-La Roche Ltd., Gen-Probe, Inc., Illumina, Inc., Novartis AG, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Nucleic Acid Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Indication, market is studied across Cancer, Forensic Testing, Genetic & Mitochondrial Disorders, and Infectious Disease.
  • Based on Product, market is studied across Consumables and Nucleic Acid Test Kits.
  • Based on Technique, market is studied across Probe Amplification Systems, Signal Amplification, and Target Amplification Systems.
  • Based on End User, market is studied across Hospitals, Pathology Laboratories, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising cases of cancer and other infectious diseases
      • 5.1.1.2. Increased commercialization of human genetic tests
      • 5.1.1.3. Exponential need in pandemic control and eradication
    • 5.1.2. Restraints
      • 5.1.2.1. Huge expenditure on R&D
    • 5.1.3. Opportunities
      • 5.1.3.1. Attractive funding space and government support to expand testing capabilities
      • 5.1.3.2. Increasing government approvals and reimbursements available
    • 5.1.4. Challenges
      • 5.1.4.1. Complex instrumentation and technology
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nucleic Acid Testing Market, by Indication

  • 6.1. Introduction
  • 6.2. Cancer
  • 6.3. Forensic Testing
  • 6.4. Genetic & Mitochondrial Disorders
  • 6.5. Infectious Disease

7. Nucleic Acid Testing Market, by Product

  • 7.1. Introduction
  • 7.2. Consumables
  • 7.3. Nucleic Acid Test Kits

8. Nucleic Acid Testing Market, by Technique

  • 8.1. Introduction
  • 8.2. Probe Amplification Systems
  • 8.3. Signal Amplification
  • 8.4. Target Amplification Systems

9. Nucleic Acid Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Hospitals
  • 9.3. Pathology Laboratories
  • 9.4. Research Institutes

10. Americas Nucleic Acid Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nucleic Acid Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nucleic Acid Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 23andMe, Inc.
  • 2. Abbott Laboratories
  • 3. Agilent Technologies, Inc.
  • 4. ARUP Laboratories
  • 5. Asuragen Inc.
  • 6. Beckman Coulter, Inc.
  • 7. Becton Dickinson and Company
  • 8. Bio-Rad Laboratories, Inc.
  • 9. Biomerieux SA
  • 10. Cepheid
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. Gen-Probe, Inc.
  • 13. Illumina, Inc.
  • 14. Novartis AG
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. NUCLEIC ACID TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEIC ACID TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEIC ACID TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEIC ACID TESTING MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY FORENSIC TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY GENETIC & MITOCHONDRIAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY INFECTIOUS DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY NUCLEIC ACID TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PROBE AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY SIGNAL AMPLIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY TARGET AMPLIFICATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY PATHOLOGY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEIC ACID TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES NUCLEIC ACID TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM NUCLEIC ACID TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. NUCLEIC ACID TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. NUCLEIC ACID TESTING MARKET, FPNV POSITIONING MATRIX, 2023